Board Members
Our passionate and dedicated Board of Directors is composed of leaders from diverse sectors with a range of expertise. The Board provides strategic guidance, oversees organizational initiatives, and supports our mission to transform the Canadian healthcare system through data.
President
Professor of Practice, University of Waterloo
Chair of the Board of Directors
Head of Innovation, Hoffmann-La Roche
Member, Board of Directors
Director, Evidence Generation Centre and Strategic Alliances, Johnson & Johnson Innovative Medicines
Member, Board of Directors
Director, Clinical Performance, Transformation, and Innovation, MUHC
Member, Board of Directors
President & CEO, Colorectal Cancer Canada
Member, Board of Directors
Former CEO, Jewish General Hospital
Management Team
Dedicated to ensuring operational smoothness and administrative efficiency, our management team comprised of healthcare industry professionals and expert consultants play a crucial role in overseeing day-to-day operations, managing logistics, and implementing initiatives.
General Manager, CPHIN
Innovation Leader, Hoffmann-La Roche
Chief of Staff, CPHIN
Innovation Leader, Hoffmann-La Roche
Jules Goss
Design Advisor, CPHIN
Professor, Industrial Design, OCADU
JP Marino
Strategic Advisor, CPHIN
Director, Market Access, Regeneron
Bing Hu
Data & AI Operations Advisor, CPHIN
PhD Candidate, Medical AI, University of Waterloo
Dan Zimskind
Operational & Strategic Consultant, CPHIN
Manager, ZS
Rob Chalmers
Operational & Strategic Consultant, CPHIN
Principal, ZS
Aarti Vyas
Volunteer Project Manager, CPHIN